|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A Tale of Two (Anal Fistula) Plugs: Is there a Difference in Short-Term Outcomes?显示文摘 | Buchberg Brian Masoomi Hossein Choi John Bergman Herlinda Mills Steven Stamos Michael J | 2010 | The American Surgeon2010，，10： | 2 |
| 2 | Pharmacokinetic and pharmacodynamic properties of multiple oral doses ofsitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers显示文摘 | Bergman AJ Stevens C Zhou Y | 2006 | Clin Ther2006，28，1： | 1 |
| 3 | Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin a dipeptidyl peptidase-Ⅳ inhibitor:a double-blind,randomized,placebo-controlled study in healthy male volunteers显示文摘 | BERGMAN AJ STEVENS C ZHOU Y | 2006 | Clin Ther2006，28，1： | 1 |
| 4 | Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes 显示文摘 | Herman GA Bergman A Stevens C | 2006 | J Clin Endocrinol Metab2006，91，11： | 1 |
| 5 | Effect of mod- erate hepatic insufficiency on the pharmacokinetics of phar- macokinetics of sitagIiptin显示文摘 | Migoya EM Stevens CH Bergman AJ | 2009 | Can J Clin Pharmacol2009，16，1： | 1 |
| 6 | Effect of single oral doses of sitagliptin,a dipeptidyl peptidase-4 inhibitor,on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes显示文摘 | Herman G A Bergman A Stevens C | 2006 | J Clin Endocrinol metab2006，91，11： | 1 |
| 7 | Effects of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patiants with type 2 diabetes显示文摘 | HERNAN GA BERGMAN A STEVENS C | 2006 | J Clin Endocrinol Metab2006，91，11： | 1 |
| 8 | Effect ofmoderate hepatic insuficiency on the pharmacokinetics ofsitagliptin显示文摘 | Migoya E M Stevens C H Bergman A J | 2009 | Can J Clin Pharmacol2009，16，1： | 1 |
| 9 | Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin,a dipeptidyl peptidase-IV inhibitor: a double- blind, randomized, placebo-controlled study in healthy male volunteers 显示文摘 | Bergman AJ Stevens C Zhou Y | 2006 | Clin Ther2006，28，1： | 1 |
| 10 | Polybrominated Diphenyl Ethers (PBDEs) and Bioaccumulative Hydroxylated PBDE Metabolites in Young Humans from Managua, Nicaragua显示文摘 | Athanasiadou Maria Cuadra Steven N Marsh G?ran Bergman ?ke Jakobsson Kristina | 2008 | Environmental Health Perspectives2008，，3： | 1 |
| 11 | Characterization of Photodamage to Escherichia coli in Optical Traps显示文摘 | Keir C. Neuman Edmund H. Chadd Grace F. Liou Keren Bergman Steven M. Block | 1999 | Biophysical Journal1999，，5： | 1 |
| 12 | Effeetsin of single oral doses of sitagliptin, a dipeptidyl peptidase-4inhibitor, on ineretin and plasma glueese levels after an oral glucose tolerance test in patients with type 2diabetes显示文摘 | Herman GA Bergman A Stevens C et 02 | 2006 | Clin Endoerinol bletab2006，91，1： | 1 |
| 13 | Effect of single oral doses of sitagliptin,a dipeptidyl peptidase-4 inhibitor,on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes显示文摘 | HERMAN GA BERGMAN A STEVENS C | 2006 | J Clin Endocrinol Metab2006，91，11： | 1 |
| 14 | Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin,a dipeptidyl peptidase-Ⅳ inhibitor:a double-blind,randomized,placebo-controlled study in healthy male volunteers显示文摘 | BERGMAN AJ STEVENS C ZHOU Y | 2006 | Clin Ther2006，28，1： | 1 |
| 15 | Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers显示文摘 | Bergman AJ Stevens C Zhou Y | 2006 | Clin Yher2006，28，： | 1 |
| 16 | Multiple dose administration ofMK-0431, a dipeptidyl peptidase IV (DPP-IV) inhibitor, in healthy malesubjects显示文摘 | Bergman A Stevens C Zhou Y | 2005 | Diabetes2005，54，1： | 1 |
| 17 | Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin 显示文摘 | Migoya EM Stevens CH Bergman AJ | 2009 | Can J Clin Pharmacol2009，16，1： | 1 |
| 18 | Lack of a clinically meaningfuleffect on age, gender or obesity on the pharmacokinetics of the DPP-IVinhibitor MK-0431 显示文摘 | Bergman A Stevens C Yi B | 2005 | Diabetes2005，54，1： | 1 |
| 19 | Pharmacokinetic andpharmacodynamic properties of multiple oral doses of sitagliptin, adipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers显示文摘 | Bergman A J Stevens C Zhou YY | 2006 | Clinical Therapeutics2006，28，1： | 1 |
| 20 | Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin andplasma glucose levels after an o- ral glucose tolerance test in patients with type 2 diabetes 显示文摘 | Herman G A Bergman A Stevens C | 2006 | J Clin Endocrinol Metab2006，91，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员